| Title |
Gabapentin for chronic neuropathic pain in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2017
|
| DOI | 10.1002/14651858.cd007938.pub4 |
| Pubmed ID | |
| Authors |
Philip J Wiffen, Sheena Derry, Rae Frances Bell, Andrew SC Rice, Thomas Rudolf Tölle, Tudor Phillips, R Andrew Moore |
X Demographics
The data shown below were collected from the profiles of 123 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 18 | 15% |
| United Kingdom | 17 | 14% |
| United States | 13 | 11% |
| Germany | 3 | 2% |
| New Zealand | 2 | 2% |
| India | 2 | 2% |
| Australia | 2 | 2% |
| Netherlands | 1 | <1% |
| Colombia | 1 | <1% |
| Other | 10 | 8% |
| Unknown | 54 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 97 | 79% |
| Practitioners (doctors, other healthcare professionals) | 16 | 13% |
| Scientists | 7 | 6% |
| Science communicators (journalists, bloggers, editors) | 3 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 792 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 792 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 110 | 14% |
| Student > Bachelor | 90 | 11% |
| Researcher | 64 | 8% |
| Student > Ph. D. Student | 56 | 7% |
| Student > Doctoral Student | 52 | 7% |
| Other | 127 | 16% |
| Unknown | 293 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 216 | 27% |
| Nursing and Health Professions | 70 | 9% |
| Neuroscience | 32 | 4% |
| Psychology | 32 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 26 | 3% |
| Other | 101 | 13% |
| Unknown | 315 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 168. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2024.
All research outputs
#247,967
of 25,884,216 outputs
Outputs from Cochrane database of systematic reviews
#404
of 13,155 outputs
Outputs of similar age
#5,170
of 335,526 outputs
Outputs of similar age from Cochrane database of systematic reviews
#14
of 246 outputs
Altmetric has tracked 25,884,216 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,155 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 246 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.